NeuroPace(NPCE) - 2024 Q2 - Quarterly Results

NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance Revenue grew to $19.3 million in Q2 2024, a 17% increase over Q2 2023 Increased full-year 2024 revenue guidance to $76 million to $78 million Demonstrated continued operating discipline as evidenced by further decrease in cash burn Management scheduled to host a conference call today at 4:30 p.m. ET Mountain View, Calif. – August 13, 2024 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transform ...